Filter
3701
Filtered Results: 3701
Text search:
drug
abuse
Featured
Recommendations
351
New Publications
962
Language
Document type
No document type
2408
Studies & Reports
495
Guidelines
430
Manuals
142
Strategic & Response Plan
100
Fact sheets
44
Training Material
39
Situation Updates
16
Brochures
11
Resource Platforms
7
Infographics
7
Dashboards/Maps
1
Videos
1
Countries / Regions
India
240
Kenya
112
Global
102
South Africa
100
Ethiopia
90
Western and Central Europe
85
Uganda
76
Nigeria
74
Liberia
64
Tanzania
62
Zambia
57
Myanmar / Burma
56
Malawi
55
Nepal
54
Sierra Leone
54
Bangladesh
49
Ghana
48
Africa
48
Ukraine
47
Latin America and the Carribbean
41
Eastern Europe
39
Namibia
36
Philippines
33
Rwanda
31
Asia
31
Russia
29
Lesotho
28
South–East Asia Region
28
Zimbabwe
25
Cambodia
22
Indonesia
22
Botswana
21
Syria
20
Eswatini/ Swaziland
19
Congo, Democratic Republic of
18
Germany
15
USA
14
Senegal
12
Burkina Faso
12
Venezuela
10
West and Central Africa
10
Middle East and North Africa
10
South Sudan
10
Cameroon
9
Mozambique
9
Haiti
9
Eastern Europe and Central Asia
9
East and Southern Africa
9
Georgia
9
Pakistan
9
Tajikistan
8
Colombia
8
Albania
8
Thailand
7
Brazil
7
Sudan
7
Afghanistan
6
Yemen
6
North Macedonia
5
Mexico
5
China
5
Guinea
5
Western Pacific Region
5
Vietnam
5
Somalia
5
Armenia
4
United Kingdom
4
Argentina
4
Lebanon
4
Moldova
4
Sri Lanka
4
Central African Republic
4
Bhutan
4
Iraq
4
Laos
3
Jordan
3
Paraguay
3
Jamaica
3
Belarus
3
Southern Africa
3
Papua New Guinea
3
Palestine
3
Madagascar
3
Timor Leste/ East Timor
2
El Salvador
2
Turkey
2
Benin
2
Kazakhstan
2
Iran
2
Canada
2
Kyrgyzstan
2
Uzbekistan
2
Peru
2
Morocco
2
Hungary
2
Saudi Arabia
2
Tunisia
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Mali
2
Libya
2
North Korea
1
Serbia
1
Australia
1
Gambia
1
Chile
1
Fiji
1
Singapore
1
Estonia
1
Malaysia
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
North America
1
Gabon
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Norway
1
Spain
1
Djibouti
1
Egypt
1
Greece
1
Poland
1
Angola
1
Chad
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1398
Clinical Guidelines
347
Public Health
188
Women & Child Health
157
Capacity Building
59
Key Resources
56
Pharmacy & Technologies
42
Toolboxes
Mental Health
595
HIV
417
TB
277
COVID-19
150
AMR
133
NCDs
95
NTDs
89
Pharmacy
83
Caregiver
63
Refugee
59
Disability
59
Rapid Response
55
Ebola
44
Conflict
42
Global Health Education
38
Planetary Health
37
Health Financing Toolbox
20
Natural Hazards
17
Social Ethics
15
Polio
13
Specific Hazards
10
Cholera
10
Zika
9
Health Financing
1
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
El grupo de Farmacovigilancia de la red Panamericana para la Armonización Farmacéutica (PARF) de la Organización Panamericana de la Salud (OPS), ha desarrollado este documento desde la visión OPS/OMS, considerando que la farmacovigilancia es un componente esencial de los programas de salud públ...
Lancet Planet Health 2022;6: e760–68
The emergence of COVID-19 has drawn the attention of health researchers sharply back to the role that food systems can play in generating human disease burden. But emerging pandemic threats are just one dimension of the complex relationship between agriculture...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10...
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
Indian markets caused a stir across the country.1
According to the Centre for Science and the Environment (CSE), a respected New Delhi-based NGO, most honey brands
sold in India contained varying amounts of antibiotics. Their consumption over time could induce resistance to antibiotics,
putting p...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph ...
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co...
